Gelteq Technology Supports U.S. Launch of Nutraceutical Products for Partner
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Sep 12 2025
0mins
Source: Newsfilter
Gelteq's U.S. Market Entry: Gelteq Limited has successfully transitioned from research and development to active commercialization in the U.S. market through its collaboration with Healthy Extracts, which has launched products utilizing Gelteq's gel-based delivery technology.
Growth Potential and Consumer Demand: The partnership highlights the potential for Gelteq's innovative gel technology in large-scale wellness markets, addressing consumer needs for convenient and clinically-informed nutraceutical solutions.
Analyst Views on GELS
About GELS
Gelteq Limited is an Australia-based clinical and science-based company. The Company is focused on developing and commercializing white-label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care and other products. The Company offers a complete end-to-end service for the development of new products and the conversion of existing products and formulations into gels. Its product suite consists of multiple products that sit within five core verticals - for pets, sports, pharmaceuticals (pharma), over-the-counter (OTC) and nutraceuticals. The Company’s delivery system provides pharma and nutraceutical enhancements throughout every stage of ingestion in both animals and humans, addressing the complete experience from the point of ingestion to final absorption. The Company also offers a versatile portfolio of pre-tested and market-ready proprietary formulations that can be white-labelled.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
